Neurocrine Biosciences (NBIX)'s 30-day implied volatility (IV30) was 42.1% at the close on October 27, 2026, down from 43.2% the day before, against a 52-week range of 24.3% to 53.7%. Its 20-day historical volatility was 26.8%.
Data as of October 27, 2026.